Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-010104
Filing Date
2023-03-31
Accepted
2023-03-31 13:54:37
Documents
76
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1695899
2 ex23-1.htm EX-23.1 4582
3 ex31-1.htm EX-31.1 22028
4 ex31-2.htm EX-31.2 22133
5 ex32.htm EX-32 10790
  Complete submission text file 0001493152-23-010104.txt   6936067

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bixt-20221231.xsd EX-101.SCH 54685
7 XBRL CALCULATION FILE bixt-20221231_cal.xml EX-101.CAL 52574
8 XBRL DEFINITION FILE bixt-20221231_def.xml EX-101.DEF 239657
9 XBRL LABEL FILE bixt-20221231_lab.xml EX-101.LAB 419680
10 XBRL PRESENTATION FILE bixt-20221231_pre.xml EX-101.PRE 354666
70 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 956166
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35027 | Film No.: 23786501
SIC: 2834 Pharmaceutical Preparations